Evidence map›Paper›PMID 28386738›Full record

ArticleDrugs in R&D2017

Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap

Rainer Winstel, Juergen Wieland, Beate Gertz, Arnd Mueller, Hermann Allgaier

Open access · goldAbstract read
In one paragraph

Article in Drugs in R&D, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rainer WinstelTeva Biotech GmbH, Member of the Teva Group, Dornierstrasse 10, 89079, Ulm, Germany. rainer.winstel@ratiopharm.de.
Juergen WielandTeva Biotech GmbH, Member of the Teva Group, Dornierstrasse 10, 89079, Ulm, Germany.
Beate GertzMerckle GmbH, Member of the Teva Group, Graf-Arco-Straße 3, 89079, Ulm, Germany.
Arnd MuellerMerckle GmbH, Member of the Teva Group, Graf-Arco-Straße 3, 89079, Ulm, Germany.
Hermann AllgaierTeva Biotech GmbH, Member of the Teva Group, Dornierstrasse 10, 89079, Ulm, Germany.
Teva Pharmaceuticals (Germany) · DEMerck (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovaleap

Indexed as

Biosimilar PharmaceuticalsFollicle Stimulating HormoneFollicle Stimulating Hormone, HumanHumansOvulation InductionRecombinant ProteinsBiosimilar PharmaceuticalsFollicle Stimulating HormoneFollicle Stimulating Hormone, Humanfollitropin alfaRecombinant Proteins

Identifiers

PMID28386738
PMCPMC5427053
OpenAlexW2604742725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.